SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 39 filers reported holding SAB BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $140 | -99.9% | 236,621 | -14.0% | 0.00% | -20.0% |
| Q3 2022 | $193,000 | -51.6% | 275,000 | 0.0% | 0.01% | -50.0% |
| Q2 2022 | $399,000 | -61.4% | 275,000 | 0.0% | 0.01% | -61.5% |
| Q1 2022 | $1,034,000 | -44.8% | 275,000 | +14.7% | 0.03% | -45.8% |
| Q4 2021 | $1,872,000 | – | 239,750 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First PREMIER Bank | 807,535 | $509 | 0.16% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 192,027 | $120,977 | 0.02% |
| LGL PARTNERS, LLC | 23,000 | $14,490 | 0.00% |
| Strategic Financial Concepts, LLC | 15,027 | $9,467 | 0.00% |
| Elgethun Capital Management | 9,935 | $6,358 | 0.00% |
| PATHSTONE FAMILY OFFICE, LLC | 506,513 | $319,103 | 0.00% |
| PEAPACK GLADSTONE FINANCIAL CORP | 52,296 | $33 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 277,777 | $174,999 | 0.00% |
| Gs Investments, Inc. | 2,000 | $1,260 | 0.00% |
| Nadler Financial Group, Inc. | 13,750 | $8,663 | 0.00% |